Latest Share Chat

REMOVE ADS

MTFB.L Regulatory News (MTFB)

MTFB.L Information

There is currently no data for MTFB

REMOVE ADS

Motif Bio

19 Mar 2020 17:30

RNS Number : 8768G

FTSE Russell

19 March 2020

Motif Bio (UK): Constituent DeletionChanges in FTSE UK Index Series

19 March 2020

Following the reclassification to AIM Rule 15 (Cash Shell) for Motif Bio (UK, constituent), please see details of affected indexes and effective dates below:

Index	Effective FromStart of Trading
FTSE AIM All-Share Index	24 March 2020

For further information please contact FTSE Russell Client Services at info@ftserussell.com or call:

Australia	+1800 653 680
Hong Kong	+852 2164 3333
Japan	+81 3 4563 6346
London	+44 (0) 20 7866 1810
New York	+1866 551 0617

Alternatively please visit our website at www.ftserussell.com

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

END

FTSUKSNRRSUOAAR

Date		Source	Headline
22nd Jul 2015	4:32 pm	RNS	FDA QIDP Designation
22nd Jul 2015	7:00 am	RNS	Final condition of £22m placing satisfied
20th Jul 2015	7:00 am	RNS	Exercise of Options
17th Jul 2015	7:00 am	RNS	FDA QIDP Designation for Iclaprim for HABP
15th Jul 2015	7:00 am	RNS	New Addition to Scientific Advisory Board
10th Jul 2015	3:29 pm	RNS	Exercise of Options
10th Jul 2015	1:37 pm	RNS	Result of General Meeting
23rd Jun 2015	8:47 am	RNS	Partner Company raises £22 million
23rd Jun 2015	7:00 am	RNS	Placing to raise £22 million and Change of Adviser
9th Jun 2015	7:00 am	RNS	Audited Non-Statutory Financial Statements
4th Jun 2015	4:41 pm	RNS	Second Price Monitoring Extn
4th Jun 2015	4:35 pm	RNS	Price Monitoring Extension
1st Jun 2015	7:00 am	RNS	Motif partners with Leading Global CRO
28th May 2015	7:00 am	RNS	FDA Meeting Minutes Confirming Iclaprim Phase III
12th May 2015	7:01 am	RNS	MOTIF SELECTED TO PRESENT AT BIOTECH EVENT
7th May 2015	7:00 am	RNS	Funding Strategy Update
15th Apr 2015	7:01 am	RNS	FDA Results
15th Apr 2015	7:00 am	RNS	FDA agree to enter clinical development programme
2nd Apr 2015	7:00 am	RNS	First Day of Dealings

Latest Share Chat

MTFB.L Regulatory News (MTFB)

Motif Bio

Please enter at least 2 characters

No results found

Search results

Recently viewed

Trending